UnitedHealth Group Incorporated (UNH)
Quarterly indicator history, curated for fast reading.
Exchange
NYSE
IPO Date
Oct 17, 1984
Shares Outstanding
905.84M
Market Cap
$257.42B
Price
$284.18-2.75 (-0.96%)● Live
Rule of 402025 Q3
16.7
✗ Below 40
Revenue Growth YoY+12.2%
+
FCF Margin+4.5%
History
Revenue
Unit: USD · Scale: ones
2025 Q3
$113,161,000,000
EPS
Unit: USD per share · Scale: ones
2025 Q3
$2.59
P/E Ratio
Unit: x · Scale: ones
2025 Q3
17.9
Free cash flow
Unit: USD · Scale: ones
2025 Q3
$5,055,000,000
Company timeline
Earnings release dates
| Quarter | End date | Publication date | Source |
|---|---|---|---|
| 2025 Q4 | 2025-12-31 | 2026-01-27 | Link |
| 2025 Q3 | 2025-09-30 | 2025-10-28 | Link |
| 2025 Q2 | 2025-06-30 | 2025-07-29 | Link |
| 2025 Q1 | 2025-03-31 | 2025-04-17 | Link |
| 2024 Q4 | 2024-12-31 | 2025-01-16 | Link |
| 2024 Q3 | 2024-09-30 | 2024-10-15 | Link |
| 2024 Q2 | 2024-06-30 | 2024-07-16 | Link |
| 2024 Q1 | 2024-03-31 | 2024-04-16 | Link |
| 2023 Q4 | 2023-12-31 | 2024-01-12 | Link |
| 2023 Q3 | 2023-09-30 | 2023-10-13 | Link |
| 2023 Q2 | 2023-06-30 | 2023-07-14 | Link |
| 2023 Q1 | 2023-03-31 | 2023-04-14 | Link |
| 2022 Q4 | 2022-12-31 | 2023-01-13 | Link |
| 2022 Q3 | 2022-09-30 | 2022-10-14 | Link |
| 2022 Q2 | 2022-06-30 | 2022-07-15 | Link |
| 2022 Q1 | 2022-03-31 | 2022-04-14 | Link |
| 2021 Q4 | 2021-12-31 | 2022-01-19 | Link |
| 2021 Q3 | 2021-09-30 | 2021-10-14 | Link |
| 2021 Q2 | 2021-06-30 | 2021-07-15 | Link |
| 2021 Q1 | 2021-03-31 | 2021-04-15 | Link |
| 2020 Q4 | 2020-12-31 | 2021-01-20 | Link |
| 2020 Q3 | 2020-09-30 | 2020-10-14 | Link |
| 2020 Q2 | 2020-06-30 | 2020-07-15 | Link |
| 2020 Q1 | 2020-03-31 | 2020-04-15 | Link |
Leadership
Key Players
Stephen J. Hemsley
Chairman & CEO
Appointed CEO in May 2025 after Andrew Witty stepped down; has served as board Chair since 2019 and previously as CEO from 2006-2017.
Wayne S. DeVeydt
CFO
Appointed CFO in September 2025; former Anthem CFO (2007-2016) and Surgery Partners CEO; most recently a managing director at Bain Capital.
Tim Noel
CEO, UnitedHealthcare
Leads the health insurance division; joined UnitedHealthcare in 2007; succeeded Brian Thompson as CEO in January 2025; previously led Medicare Advantage plans.
Dr. Patrick Conway, M.D.
CEO, Optum
Appointed Optum CEO in May 2025; previously CEO of Optum Rx; practicing pediatrician with extensive public and private health care leadership experience.
Heather Cianfrocco
EVP, Governance, Compliance & Information Security
Moved from Optum CEO role in May 2025; previously held senior leadership roles across UnitedHealthcare and Optum; former practicing lawyer.
John F. Rex
Strategic Advisor to CEO
Former CFO (2016-2025); transitioned to advisory role in September 2025; joined UnitedHealth Group in 2012 as Optum CFO.
Charles Baker
Independent Director
President of the NCAA; former Governor of Massachusetts (2015-2023); joined board in 2023.
Timothy Flynn
Lead Independent Director
Former Chairman of KPMG International; joined board in 2017; serves as Lead Independent Director.
Paul Garcia
Independent Director
Retired Chairman and CEO of Global Payments, Inc.; joined board in 2021; fintech and payments expertise.
Kristen Gil
Independent Director
Former VP and Business Finance Officer at Alphabet, Inc.; joined board in 2022; technology and finance expertise.
Michele Hooper
Independent Director
President and CEO of The Directors' Council; joined board in 2007; longest-serving independent director.
F. William McNabb III
Independent Director
Former Chairman and CEO of The Vanguard Group, Inc.; joined board in 2018; investment management and governance expertise.
Valerie Montgomery Rice, M.D.
Independent Director
President and CEO of Morehouse School of Medicine; joined board in 2017; medical education and health equity expertise.
John Noseworthy, M.D.
Independent Director
Former CEO and President of Mayo Clinic; joined board in 2019; health care delivery and clinical expertise.
Short Interest
Short interest data unavailable for UNH.